• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Wearable Sensor Administers Narcan to Prevent Opioid Overdose Deaths

Share:

August 7, 2019

In the United States, more than 130 people die after overdosing on opioids every day. Devastating consequences of the opioid epidemic include increases in opioid misuse and related overdoses, as well as the rising incidence of newborns experiencing withdrawal syndrome due to opioid use and misuse during pregnancy, according to the U.S. Dept. of Health and Human Services.

A drug called Narcan is used as an antidote for opioid overdose, but it’s difficult for a patient to administer it by themselves. Researchers from Purdue University have decided to tackle this problem with a wearable system that will release the antidote automatically, reports MobiHealthNews.

“A lot of time patients who overdoes are found alone and are incapacitated to inject the life-saving drug themselves,” Hyowon “Hugh” Lee, an assistant professor of biomedical engineering at Purdue, said in a university video. “We are trying to come up with a closed loop solution that can automatically deliver an antidote.”

An overdose occurs when opioids adhere to brain receptors that control breathing, causing individuals to hypoventilate and die.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The wearable device can detect the point at which the respiration rate of a person decreases to a certain level – changed from electrocardiography (EKG) signals – and subsequently releases the drug. This drug blocks the opioid from adhering to brain receptors.

Just like an insulin pump, the proof of concept device is worn as an armband that fastens to a magnetic field generator, linked to a portable battery worn at the hip.

“The idea is to be able to measure the rate of respiration using some sort of wearable sensor, and then to be able to use that as some form of threshold to trigger the release of the antidote that will be implanted under the skin so you will have an antidote with you just in case you have some sort of an accident,” Lee said. “Then when the system texts that you are having respiratory failure the drug will be released automatically to give you extra time to get medical attention.”

An EKG sensor is adhered on the chest. When it detects a respiration that’s too low, it triggers the magnetic field generator to warm up a drug capsule within the body and discharges the antidote in 10 seconds.

The scientists believe the drug capsule can be pre-injected within the skin in an outpatient setting. The device therefore would be able to automatically release the drug to the patient in case of an overdose. That would give emergency services an extra hour to get the patient to the hospital, Lee said.

Date: August 7, 2019

Source: Wearable Technologies

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • GHX Acquires Lumere to Advance Clinically Integrated Supply ChainsGHX Acquires Lumere to Advance Clinically Integrated Supply Chains
  • IBM Watson Health to Launch Blockchain-powered Digital Health PassIBM Watson Health to Launch Blockchain-powered Digital Health Pass
  • Healthify, Algorex Health & Excellus BCBS Tap into SDoH Analytics to Address Social DisparitiesHealthify, Algorex Health & Excellus BCBS Tap into SDoH Analytics to Address Social Disparities
  • 5 Critical Considerations for Patient Privacy in Telehealth5 Critical Considerations for Patient Privacy in Telehealth
  • Senior-focused health tech company PointClickCare acquires QuickMar, maker of post-acute care management systemSenior-focused health tech company PointClickCare acquires QuickMar, maker of post-acute care management system
  • Kronos Bio and Gilead Sciences Enter Into Asset Purchase Agreement for Gilead’s SYK Inhibitor PortfolioKronos Bio and Gilead Sciences Enter Into Asset Purchase Agreement for Gilead’s SYK Inhibitor Portfolio
  • Digital Diabetes Market to Reach $1.5B by 2024, Research FindsDigital Diabetes Market to Reach $1.5B by 2024, Research Finds
  • Rock Health Report: Is 2019 The Year of the Digital Health IPO?Rock Health Report: Is 2019 The Year of the Digital Health IPO?

Trending This Week

  • Pharmaceutical Logistics Market 2020 Size, Growth Rate, Share, Statistics, Trends, COVID-19 Impact, Key PlayerS
  • Hepcidin Market Insights, Trends, Size, Share and Forecast 2020 – 2027
  • COVID-19 Drug API Market is set for Lucrative Growth
  • Vitamins and Minerals Market Trends, Insights and Forecast 2020 – 2027
  • Global COVID-19 Treatment Industry Top-Vendor And Industry Insights By End-User Segments Till 2027
  • Revive Therapeutics Acquires Unique Psilocybin Assets

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications